Back to HALO
KENNEDY CAPITAL MANAGEMENT LLC → HALO
KENNEDY CAPITAL MANAGEMENT LLC HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$47.2M
Q3 2026
Peak value
$47.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $29.2M |
| Q1 2026 | $31.3M |
| Q2 2026 | $42.7M |
| Q3 2026 | $47.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $47.2M | 427.5K | — | — |
| Q2 2026 | $42.7M | 545.0K | — | — |
| Q1 2026 | $31.3M | 484.6K | — | — |
| Q4 2025 | $29.2M | 433.8K | — | — |
Other funds holding HALO
$915.4M
$649.5M
$559M
$545.3M
$539.3M
$531.8M